apomorphine


EMA3



General information:


Withdrawn ID: EMA3
Canonical SMILES:
Standard InChI:
Standard InChIKey:
ATC class(es): G04BE07
N04BC07
Molecular Formula: C17H17NO2
Molweight: 267.322



Withdrawal information:


Withdrawn due to drug safety reasons:No



Side-effects:

Total reported cases (submitted by medical professionals) with apomorphine as primary suspect: 368


Reported final outcomes:
Hospitalization (initial or prolonged): 97
Death: 40
Disability: 6
Intervention required to prevent permanent impairment/damage: 5
Life-Threatening condition: 4


Reported side-effects:

Side-effect Case number
NAUSEA66
FALL37
DIZZINESS36
DRUG INEFFECTIVE33
SOMNOLENCE31
VOMITING29
BLOOD PRESSURE DECREASED28
HYPOTENSION27
DEATH24
HYPERHIDROSIS19
HALLUCINATION18
DYSKINESIA18
BLOOD PRESSURE INCREASED18
DYSPNOEA16
CONFUSIONAL STATE16
YAWNING15
Off label use14
LOSS OF CONSCIOUSNESS12
FATIGUE12
CONDITION AGGRAVATED12
TREMOR11
ASTHENIA11
MYOCARDIAL INFARCTION10
INJECTION SITE BRUISING9
URINARY TRACT INFECTION8
Injection site pruritus8
HIP FRACTURE8
HEADACHE8
SYNCOPE7
RHINORRHOEA7
Parkinson's disease7
PALLOR7
Lip swelling7
HEART RATE INCREASED7
FLUSHING7
FEELING HOT7
FEELING ABNORMAL7
ERYTHEMA7
CONTUSION7
CHEST PAIN7
ANXIETY7
On and off phenomenon6
OEDEMA PERIPHERAL6
Injection site erythema6
INCORRECT DOSE ADMINISTERED6
HYPERTENSION6
DYSSTASIA6
VISION BLURRED5
UNRESPONSIVE TO STIMULI5
Stomatitis5
RASH5
PYREXIA5
PRURITUS5
PNEUMONIA5
PAIN IN EXTREMITY5
MALAISE5
Injection site reaction5
HEART RATE DECREASED5
HALLUCINATION, VISUAL5
DYSPHAGIA5
COUGH5
COLD SWEAT5
TRANSIENT ISCHAEMIC ATTACK4
SEPSIS4
Retching4
PARANOIA4
JOINT DISLOCATION4
Hypersensitivity4
HOT FLUSH4
HOSPITALISATION4
GENERAL PHYSICAL HEALTH DETERIORATION4
DYSGEUSIA4
DRY MOUTH4
DROOLING4
DEHYDRATION4
CARDIAC FAILURE CONGESTIVE4
BLOOD PRESSURE FLUCTUATION4
Agitation4
Abdominal discomfort4
Urticaria3
UPPER LIMB FRACTURE3
Throat irritation3
Thinking abnormal3
SWELLING3
Product dose omission3
Presyncope3
Prescribed overdose3
Peripheral swelling3
PALPITATIONS3
PAIN3
Oral pain3
Musculoskeletal stiffness3
MUSCLE RIGIDITY3
Mouth ulceration3
LIMB DISCOMFORT3
LETHARGY3
INSOMNIA3
Injection site swelling3
Injection site rash3
Injection site pain3
Injection site mass3
Impaired quality of life3
DRUG EFFECT DECREASED3
Disease progression3
Diarrhoea3
DEPRESSED LEVEL OF CONSCIOUSNESS3
Chills3
CEREBROVASCULAR ACCIDENT3
CELLULITIS3
CARDIO-RESPIRATORY ARREST3
CARDIAC DISORDER3
BLOOD PRESSURE SYSTOLIC INCREASED3
BLOOD PRESSURE SYSTOLIC DECREASED3
ABNORMAL BEHAVIOUR3
ABDOMINAL PAIN UPPER3
Weight decreased2
THIRST2
Therapy cessation2
SWOLLEN TONGUE2
SWELLING FACE2
Staphylococcal infection2
Sneezing2
Skin discolouration2
Restlessness2
RESPIRATORY RATE DECREASED2
Respiratory failure2
Psychotic disorder2
PNEUMONIA ASPIRATION2
Peripheral coldness2
PARAESTHESIA2
OVERDOSE2
ORTHOSTATIC HYPOTENSION2
Oral pruritus2
Myalgia2
Muscle spasms2
MOVEMENT DISORDER2
MOBILITY DECREASED2
MENTAL STATUS CHANGES2
Memory impairment2
Intentional product use issue2
Injection site warmth2
Injection site nodule2
Injection site haemorrhage2
INFECTION2
INCREASED UPPER AIRWAY SECRETION2
INCORRECT DRUG ADMINISTRATION DURATION2
Impulsive behaviour2
HYPOAESTHESIA2
HEAD INJURY2
Head discomfort2
HAEMORRHAGE2
HAEMOLYTIC ANAEMIA2
GAIT DISTURBANCE2
FEELING COLD2
Dystonia2
Dysarthria2
Drug monitoring procedure not performed2
Drug interaction2
DRUG HYPERSENSITIVITY2
Drug dependence2
DELUSION2
DECUBITUS ULCER2
CRYING2
CONVULSION2
CLAVICLE FRACTURE2
CHRONIC OBSTRUCTIVE PULMONARY DISEASE2
CHEST DISCOMFORT2
Cardiac flutter2
Cardiac arrest2
Bradycardia2
BLOOD SODIUM DECREASED2
Blindness2
ATRIAL FIBRILLATION2
ASPIRATION2
Angioedema2
ANAEMIA2
AGGRESSION2
ABDOMINAL PAIN2
ABASIA2
Wrong technique in product usage process1
Weight increased1
Visual impairment1
VIRAL INFECTION1
Ventricular fibrillation1
URINARY TRACT DISORDER1
Treatment noncompliance1
Transient global amnesia1
Tooth loss1
TOOTH FRACTURE1
Tooth discolouration1
TONGUE DRY1
Tongue blistering1
THROMBOSIS1
Throat tightness1
Throat clearing1
Therapy interrupted1
Therapy change1
Therapeutic response unexpected1
Therapeutic response increased1
SUICIDE ATTEMPT1
Suicidal ideation1
SUBDURAL HYGROMA1
SUBARACHNOID HAEMORRHAGE1
Stress1
SPLENOMEGALY1
Spinal fracture1
SPINAL COLUMN STENOSIS1
Speech disorder1
SLEEP WALKING1
Sleep disorder1
Skin ulcer1
SKIN REACTION1
Skin necrosis1
Skin lesion1
SKELETAL INJURY1
Sexually inappropriate behaviour1
Sensation of foreign body1
Secretion discharge1
Rotator cuff repair1
Road traffic accident1
RIB FRACTURE1
RETROPERITONEAL FIBROSIS1
RETINAL DETACHMENT1
RESPIRATORY RATE INCREASED1
Respiratory disorder1
RENAL FAILURE1
Renal disorder1
Rash pruritic1
PULMONARY THROMBOSIS1
Pulmonary oedema1
Pulmonary embolism1
Pulmonary congestion1
Productive cough1
Product use issue1
Product use complaint1
Product solubility abnormal1
Product quality issue1
Product prescribing issue1
Product dose omission issue1
Product administration error1
Prescription drug used without a prescription1
POSTURE ABNORMAL1
Pollakiuria1
Physical deconditioning1
PATHOLOGICAL GAMBLING1
Parkinsonism1
Paranasal sinus discomfort1
Panic disorder1
PANIC ATTACK1
PANCREATITIS1
PAIN IN JAW1
Osteomyelitis1
Oropharyngeal pain1
Oral discomfort1
Oral candidiasis1
Oesophageal disorder1
Ocular hyperaemia1
Obsessive-compulsive disorder1
Nodule1
No therapeutic response1
Nightmare1
NIGHT SWEATS1
Neuroleptic malignant syndrome1
Neuroendocrine carcinoma of the skin1
Nervousness1
NERVE COMPRESSION1
Nasal congestion1
Musculoskeletal pain1
Muscle strain1
Muscle injury1
Mouth swelling1
Mood altered1
Mental disorder1
Mania1
MALNUTRITION1
Malignant neoplasm progression1
MALABSORPTION FROM INJECTION SITE1
Macular degeneration1
Lower respiratory tract infection1
LOWER LIMB FRACTURE1
LOW DENSITY LIPOPROTEIN INCREASED1
Logorrhoea1
LOCALISED INFECTION1
Limbal swelling1
Ligament sprain1
Libido increased1
Leg amputation1
LACUNAR INFARCTION1
LABILE BLOOD PRESSURE1
Joint swelling1
JOINT LOCK1
INTRAVENTRICULAR HAEMORRHAGE1
INTERVERTEBRAL DISC PROTRUSION1
Instillation site pruritus1
Injury associated with device1
Injection site infection1
Injection site induration1
Injection site hypoaesthesia1
Injection site hypersensitivity1
INJECTION SITE HAEMATOMA1
Injection site discolouration1
INFUSION SITE ULCER1
INFUSION SITE NECROSIS1
INFLAMMATION1
Incorrect route of product administration1
Incorrect dose administered by device1
Impulse-control disorder1
Immobile1
IMMEDIATE POST-INJECTION REACTION1
Illness1
Hypoxia1
Hypophagia1
Hypoaesthesia oral1
Hypoacusis1
Hypersomnia1
HILAR LYMPHADENOPATHY1
HIATUS HERNIA1
Hemiplegia1
Gingivitis1
Gastroenteritis viral1
Gait inability1
FLANK PAIN1
Fear of falling1
Faeces soft1
FACIAL PALSY1
EYE SWELLING1
EYE ROLLING1
EXTRASYSTOLES1
EXCORIATION1
Enuresis1
Eating disorder1
Dysuria1
Dysgraphia1
Drug intolerance1
Drug effect incomplete1
Drug effect delayed1
Drug abuse1
Dizziness postural1
Disorientation1
DISEASE RECURRENCE1
Discomfort1
Diplopia1
Diaphragmatic disorder1
Device issue1
Device failure1
Device breakage1
DEPRESSION1
Dependence1
Delirium1
Decreased appetite1
COOMBS POSITIVE HAEMOLYTIC ANAEMIA1
Contraindication to medical treatment1
COMMUNICATION DISORDER1
Cognitive disorder1
CHOLECYSTECTOMY1
Cervical vertebral fracture1
Cerebral haemorrhage1
CEREBRAL ATROPHY1
CATHETER RELATED COMPLICATION1
Catatonia1
Cardiomyopathy1
Camptocormia1
Bursitis1
BRONCHITIS1
Bronchial secretion retention1
BRAIN CONTUSION1
Bradyphrenia1
BRACHIAL PLEXUS INJURY1
BODY TEMPERATURE INCREASED1
BLOOD URINE PRESENT1
Blood pressure inadequately controlled1
BLOOD PRESSURE DIASTOLIC INCREASED1
BLOOD PRESSURE DIASTOLIC DECREASED1
BLOOD PRESSURE ABNORMAL1
Blood glucose decreased1
Balance disorder1
Back pain1
ASTHMA1
ARTHRITIS1
APPARENT LIFE THREATENING EVENT1
Aphthous ulcer1
Aphasia1
Aphagia1
ANURIA1
Anger1
Adverse reaction1
ADVERSE DRUG REACTION1
Adjustment disorder with depressed mood1
ACUTE PSYCHOSIS1
Acute kidney injury1
Activities of daily living impaired1
Abnormal sensation in eye1
Abnormal dreams1





Filtered ChEMBL targets:

Target UniProtKB ID Activity in nm Target Name Target gene
P04637 6309.6 Cellular tumor antigen p53 P53_HUMAN
P08908 117 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN
P14416 0.62 D(2) dopamine receptor DRD2_HUMAN
P15428 3981.1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] PGDH_HUMAN
P21728 3.77 D(1A) dopamine receptor DRD1_HUMAN
P21917 4.3 D(4) dopamine receptor DRD4_HUMAN
P21918 15 D(1B) dopamine receptor DRD5_HUMAN
P28223 120 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN
P35462 2.6 D(3) dopamine receptor DRD3_HUMAN
Q00987 195 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN
Q99714 20 3-hydroxyacyl-CoA dehydrogenase type-2 HCD2_HUMAN
Q9NUW8 281.8 Tyrosyl-DNA phosphodiesterase 1 TYDP1_HUMAN



Toxicity information:

Toxicity class: 3
Toxicity type: N/A
LD50: 240 mg/kg



External links:

ChEBML: CHEMBL53
DrugBank: DB00714